Providence Health Care is set to build a local technology innovation hub. The Vancouver-based Catholic healthcare community platform intends to establish the hub within St. Paul’s Hospital and Clinical Support and Research Centre, which will be connected via skybridge to the new St. Paul’s Hospital on the Jim Pattison Medical Campus. The CSRC’s innovation hub […]
Aspect Biosystems
Aspect Biosystems Garners Funding for Big Project Targeting Disease Solutions
Aspect Biosystems has received substantial investment from the federal government. The Vancouver-based biotechnology company pioneering a novel category of regenerative medicine attracted $79 million from Canada as part of a multiyear, $280M project. The project will aim to accelerate the advancement of Aspect’s pipeline of bioengineered cellular medicines for serious metabolic and endocrine diseases, enhance […]
Aspect Biosystems, Novo Nordisk Deepen Collaboration on Diabetes Cell Therapies
Vancouver-based Aspect Biosystems and Danish pharmaceutical giant Novo Nordisk are expanding their partnership to advance the development of next-generation cellular medicines aimed at treating diabetes. The companies said the new phase of their collaboration builds on work underway since 2023 and reflects a shared goal of accelerating potentially curative therapies for serious metabolic diseases. Under […]
Aspect Biosystems Secures $115M to Revolutionize Regenerative Medicine
Vancouver-based Aspect Biosystems has raised an impressive USD $115 million in Series B funding, signaling a major step forward in the development of bioprinted tissue therapeutics. The financing round was led by Dimension, a life sciences and technology-focused investment firm, with participation from new and returning investors including Novo Nordisk, Radical Ventures, InBC, and others. […]
Aspect Biosystems Secures $72.75M for Bioprinted Tissue Therapeutics
Vancouver biotech Aspect Biosystems today announced that it has received a $72.75 million investment from the Governments of Canada and British Columbia. The UBC Spinout is pioneering the development of bioprinted tissue therapeutics to transform how we treat currently incurable diseases and was named to Fast Company’s annual Next Big Things in Tech list last year. […]
Aspect Biosystems Named to Fast Company’s 2023 List of the Next Big Things in Tech
UBC spinout Aspect Biosystems has been named to Fast Company’s third annual Next Big Things in Tech list, honoring technological breakthroughs that promise to shape the future of industries — from healthcare and security to artificial intelligence and data. Aspect Biosystems is applying its full-stack tissue therapeutic platform to develop a novel class of cell-based tissue […]
BC Tech Crowns Winners of 2023 Technology Impact Awards
Tonight the Technology Impact Awards (TIAs) marked their 30th Anniversary announcing 9 companies as award winners and inducting 8 leaders to the Innovators Hall of Fame at the annual awards show. “BC Tech is proud to have played a part in the journey of so many BC tech icons and success stories across our 30-year […]
BC Tech Unveils Finalists For 2023 Technology Impact Awards
The BC Tech Association has announced the finalists for the 2023 Technology Impact Awards, the 30th anniversary of the TIAs. The announcement was hosted in downtown Vancouver at The Den at Bentall Centre with a live online audience. “This year marks a big milestone for BC Tech, as we celebrate our 30th Anniversary alongside the companies […]
Aspect Biosystems Inks $75 Million Deal with Novo Nordisk to Develop Bioprinted Tissue Therapeutics for Diabetes and Obesity
UBC spinout Aspect Biosystems is collaborating with Novo Nordisk to develop bioprinted tissue therapeutics designed to replace, repair, or supplement biological functions inside the body with the aim of delivering a new class of truly disease-modifying treatments for diabetes and obesity. The collaboration will leverage Aspect’s proprietary bioprinting technology and Novo Nordisk’s expertise and technology […]
Aspect Biosystems Aims to Pioneer Regenerative Medicine with 3D Tech
A recent investment from the Pacific Economic Development Agency of Canada will help broaden the application of Aspect Biosystems’ 3D bioprinting technology for therapeutic development, expand its global network of partners, and scale-up its manufacturing systems, according to a statement issued by the Vancouver firm. Aspect, among other Vancouver tech companies receiving funding from PacifiCan’s […]